Past, Present, and Future of Plant-Derived Extracellular Vesicles in Biomedical Applications
Pharmaceuticals · 24.07.2026 · 19 (8) · 1156
DOI: 10.3390/ph19081156 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 24.07.2026. Verfasst von Yilixiati Wusiman und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, College of Pharmacy, Xinjiang Medical University, Urumqi 830017, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 219 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation for Distinguished Young Scholars of Xinjiang Autonomous Region, Tianshan Talents-Youth Science and Technology Innovation Talents Training Program of Xinjiang Autonomous Region, Xinjiang Key Laboratory of Natural Medicines Active Components and Drug Release Technology.
Abstract (Originalsprache)
Plant-derived extracellular vesicles (PDEVs) have emerged as promising natural nanocarriers for biomedical applications owing to their distinctive ability to facilitate intercellular communication and transport bioactive molecules. In this review, we employ bibliometric analysis to identify research hotspots and trends, providing a comprehensive overview of these core themes. The bibliometric results reveal a sustained increase in annual publications in this field, with keyword analysis identifying drug delivery, cross-kingdom regulation, immunomodulation, engineering modification, and gut microbiota as five major research themes. The focus of research has evolved from early basic biological characteristics into engineered smart delivery platforms, with the application areas expanding from intestinal inflammation to neurological, metabolic, dermatological, and oncological diseases. This review systematically examines the core directions in this field. It compares the strengths and limitations of mainstream isolation methods and highlights the value of multi-omics integration, covering the molecular mechanisms of ferroptosis and gut microbiota regulation by PDEVs along with engineering strategies such as drug loading, surface modification, and membrane fusion. It also discusses the latest progress in frontier therapeutic applications of PDEVs, including cancer, inflammatory diseases, tissue regeneration and aesthetics, and neurological disorders. Finally, this review summarizes the key challenges confronting the field, including the lack of standardized protocols, production bottlenecks, and engineering obstacles. It also delineates future directions, including establishing international standardization definitions, advancing multi-omics and AI-driven mechanistic elucidation, developing scalable and efficient purification technologies, and executing systematic preclinical safety and pharmacokinetic evaluations to facilitate clinical translation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacology, College of Pharmacy, Xinjiang Medical University, Urumqi 830017, China.
- Xinjiang Key Laboratory of Natural Medicines Active Components and Drug Release Technology, Urumqi 830017, China.
- Xinjiang Key Laboratory of Biopharmaceuticals and Medical Devices, Urumqi 830017, China.
- Engineering Research Center of Xinjiang and Central Asian Medicine Resources, Ministry of Education, Urumqi 830017, China.
ORCID-Profile: Yilixiati Wusiman, Dilihuma Dilimulati, Wenting Zhou
Förderung
- Natural Science Foundation for Distinguished Young Scholars of Xinjiang Autonomous Region
- Tianshan Talents-Youth Science and Technology Innovation Talents Training Program of Xinjiang Autonomous Region
- Xinjiang Key Laboratory of Natural Medicines Active Components and Drug Release Technology
- Xinjiang Key Laboratory of Biopharmaceuticals and Medical Devices
- Engineering Research Center of Xinjiang and Central Asian Medicine Resources, Ministry of Education
Zitieren
APA
Wusiman, Y., Qiu, X., Yusufujiang, N., Paerhati, Y., Aikebaier, A., Dilimulati, D., Baishan, A., & Zhou, W. (2026). Past, Present, and Future of Plant-Derived Extracellular Vesicles in Biomedical Applications. Pharmaceuticals, 19(8), 1156. https://doi.org/10.3390/ph19081156
Vancouver
Wusiman Y, Qiu X, Yusufujiang N, Paerhati Y, Aikebaier A, Dilimulati D, et al. Past, Present, and Future of Plant-Derived Extracellular Vesicles in Biomedical Applications. Pharmaceuticals. 2026;19(8):1156. doi:10.3390/ph19081156
BibTeX
@article{Wusiman2026,
author = {Wusiman, Yilixiati and Qiu, Xiaoxiao and Yusufujiang, Nazhakaiti and Paerhati, Yipaerguli and Aikebaier, Alifeiye and Dilimulati, Dilihuma and Baishan, Alhar and Zhou, Wenting},
title = {Past, Present, and Future of Plant-Derived Extracellular Vesicles in Biomedical Applications},
journal = {Pharmaceuticals},
year = {2026},
volume = {19},
number = {8},
pages = {1156},
doi = {10.3390/ph19081156}
}
EUVIMED